Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 4 September 2023
Accepted: 22 December 2023
First Online: 4 January 2024
Declarations
:
: Not applicable. The presented patient was examined under routine clinical circumstances and consented to the examinations.
: Informed consent to publish was obtained from the study participant.
: Authors CLA and ONK declare that no potential conflicts of interests exist in relation to this work. Author MS declares to have received investigator fees from Allergan, Bayer, Novartis, and Roche, and has served as an advisory board member for Novartis and Roche and acted as consultant for AbbVie, not related to this work.
